Beryl Drugs Complete Financial Statements
BERLDRG • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Beryl Drugs (BERLDRG).
Downloads include all available records across all periods.
For market performance, see the
BERLDRG stock price today
.
Profitability Ratios
Net Profit Margin
4.35%
2025 data
EBITDA Margin
13.04%
2025 data
Operating Margin
6.00%
2025 data
Return on Assets
6.25%
2025 data
Return on Equity
10.00%
2025 data
Balance Sheet Ratios
Current Ratio
4.50
2025 data
Debt to Equity
1.60
2025 data
Equity Ratio
62.50%
2025 data
Asset Turnover
1.44
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-8.7%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-33.3%
Year-over-Year
Expense Growth
-10.0%
Year-over-Year
Assets Growth
-11.1%
Year-over-Year
Equity Growth
+11.1%
Year-over-Year
Liabilities Growth
-11.1%
Year-over-Year
Operating Cash Flow Growth
+200.0%
Year-over-Year
Investing Cash Flow Growth
+100.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21 | 23 | 27 | 27 | 15 | 14 | 13 | 13 | 16 | 11 | 14 | 14 |
| Expenses | 18 | 20 | 25 | 25 | 14 | 13 | 12 | 12 | 14 | 11 | 13 | 13 |
| EBITDA | 2 | 3 | 3 | 2 | 1 | 2 | 1 | 1 | 2 | 0 | 1 | 1 |
| Operating Profit Margin % | 4.00% | 6.00% | 9.00% | 7.00% | 3.00% | 10.00% | 7.00% | 8.00% | 7.00% | -1.00% | 4.00% | 6.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Interest | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 1 | -1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 1 | 1 | -1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.50 | 1.14 | 1.52 | 1.51 | -1.30 | 0.47 | 0.09 | 1.16 | 1.96 | -0.88 | 0.33 | 0.17 |
Related Pages for Beryl Drugs
Additional stock information and data for BERLDRG
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 16 | 18 | 18 | 18 | 19 | 17 | 15 | 11 | 10 | 10 | 11 |
| Current Assets | 9 | 10 | 10 | 11 | 10 | 8 | 5 | 7 | 7 | 6 | 6 |
| Fixed Assets | 6 | 6 | 6 | 6 | 8 | 9 | 2 | 2 | 2 | 2 | 2 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 |
| Other Assets | 10 | 11 | 11 | 12 | 11 | 8 | 6 | 8 | 8 | 8 | 8 |
| LIABILITIES | |||||||||||
| Total Liabilities | 16 | 18 | 18 | 18 | 19 | 17 | 15 | 11 | 10 | 10 | 11 |
| Current Liabilities | 2 | 3 | 3 | 2 | 3 | 3 | 2 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 10 | 9 | 8 | 7 | 8 | 8 | 8 | 7 | 6 | 7 | 7 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 4 | 4 | 3 | 2 | 3 | 3 | 2 | 2 | 1 | 2 | 1 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3 | 1 | 3 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 1 |
| Investing Activities | 0 | -1 | -1 | 1 | 0 | -2 | -5 | 0 | 0 | 0 | 0 |
| Financing Activities | -2 | 0 | -1 | 0 | -1 | 2 | 2 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 0 | 1 |